Astec LifeSciences Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Burjis Godrej
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | 2.5yrs |
| Board average tenure | 5.1yrs |
Recent management updates
Recent updates
The Price Is Right For Astec LifeSciences Limited (NSE:ASTEC) Even After Diving 30%
Feb 19
Why We're Not Concerned About Astec LifeSciences Limited's (NSE:ASTEC) Share Price
Jan 04Shareholders May Be Wary Of Increasing Astec LifeSciences Limited's (NSE:ASTEC) CEO Compensation Package
Jul 23Market Participants Recognise Astec LifeSciences Limited's (NSE:ASTEC) Revenues Pushing Shares 28% Higher
Jul 03Astec LifeSciences Limited (NSE:ASTEC) Stocks Shoot Up 30% But Its P/S Still Looks Reasonable
Mar 15Astec LifeSciences (NSE:ASTEC) Could Be Struggling To Allocate Capital
May 17Shareholders Are Optimistic That Astec LifeSciences (NSE:ASTEC) Will Multiply In Value
Oct 14We Ran A Stock Scan For Earnings Growth And Astec LifeSciences (NSE:ASTEC) Passed With Ease
Jul 27Here's Why Astec LifeSciences (NSE:ASTEC) Can Manage Its Debt Responsibly
Jun 28A Look At The Intrinsic Value Of Astec LifeSciences Limited (NSE:ASTEC)
Jun 03Analysts Just Published A Bright New Outlook For Astec LifeSciences Limited's (NSE:ASTEC)
May 08Astec LifeSciences Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
May 06Why We Like The Returns At Astec LifeSciences (NSE:ASTEC)
Jan 25Is Astec LifeSciences (NSE:ASTEC) A Risky Investment?
Dec 13We Take A Look At Why Astec LifeSciences Limited's (NSE:ASTEC) CEO Has Earned Their Pay Packet
Jul 21Does Astec LifeSciences (NSE:ASTEC) Have A Healthy Balance Sheet?
May 02The Trend Of High Returns At Astec LifeSciences (NSE:ASTEC) Has Us Very Interested
Apr 17Do Astec LifeSciences's (NSE:ASTEC) Earnings Warrant Your Attention?
Apr 02Is Astec LifeSciences Limited's (NSE:ASTEC) Shareholder Ownership Skewed Towards Insiders?
Mar 18Have Insiders Been Selling Astec LifeSciences Limited (NSE:ASTEC) Shares?
Mar 05Did You Miss Astec LifeSciences' (NSE:ASTEC) Whopping 481% Share Price Gain?
Feb 20CEO
Burjis Godrej (33 yo)
Mr. Burjis Nadir Godrej is Executive Director of Godrej Agrovet Limited from November 01, 2022. He is Additional Non-Executive Non- Independent Director of Astec LifeSciences Limited from July 25, 2022 and...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD & Additional Non-Executive Non- Independent Director | less than a year | no data | no data | |
| Chief Financial Officer | 1yr | no data | no data | |
| Chief Operating Officer | 4.1yrs | ₹5.02m | no data | |
| Company Secretary & Compliance Officer | 6.8yrs | ₹1.90m | no data | |
| Vice President of Marketing | no data | no data | no data | |
| General Manager of sales | no data | no data | no data | |
| General Manager of Human Resources | no data | no data | no data | |
| GM of Operations | no data | no data | no data |
Experienced Management: ASTEC's management team is considered experienced (2.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD & Additional Non-Executive Non- Independent Director | 3.1yrs | no data | no data | |
| Non-Executive Chairman | 9.8yrs | no data | 1.81% ₹ 353.9m | |
| Non-Executive Non-Independent Director | 9.8yrs | no data | no data | |
| Non-Executive Non-Independent Director | 31.6yrs | ₹25.42m | 1.74% ₹ 341.7m | |
| Independent Director | less than a year | ₹300.00k | no data | |
| Non-Executive Independent Director | 5.6yrs | ₹1.15m | no data | |
| Non-Executive Independent Director | 4.7yrs | ₹550.00k | no data | |
| Non-Executive Independent Director | 4.7yrs | ₹800.00k | no data |
Experienced Board: ASTEC's board of directors are considered experienced (5.1 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/08/01 21:07 |
| End of Day Share Price | 2025/08/01 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Astec LifeSciences Limited is covered by 7 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | Asian Markets Securities Private Limited |
| Ankur Periwal | Axis Capital Limited |
| Satish Kumar | CGS International |